Dr. Aman Chauhan, MD

Dr. Chauhan practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Chauhan's NPI, 1902193147, was assigned on July 8, 2011. Dr. Chauhan graduated from Kasturba Medical College Manipal in 2010. Dr. Chauhan holds Florida license ME160009.

Dr. Chauhan's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Chauhan's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Chauhan is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Chauhan to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chauhan practices, 5 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Chauhan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Chauhan is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Chauhan's licenses on file in 3 states: Florida, New York and Kentucky.

Dmand AI lists lung cancer among the conditions Dr. Chauhan treats.

CMS data shows 444 Medicare services from Dr. Chauhan across 5 procedure codes in 2024, for 122 Medicare patients. Medicare paid $37,623 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 122 Medicare patients who saw Dr. Chauhan in 2024. The largest group is 65 to 74, with 57 patients. 75% of them have high blood pressure, and 66% have high cholesterol. 23% are also on Medicaid. Their average risk score is 3.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chauhan's median patient age at 69, with 49% women.

In 2024, Dr. Chauhan wrote 161 Medicare Part D claims for 51 patients. 84% of them were for generic drugs. CMS names the drug for 77 of them, across 4 drugs with 11 or more claims each, at $41,599 in total drug cost. In 2023, CMS named 79 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Chauhan for performance year 2024, reported as part of a group. Dr. Chauhan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chauhan as offering telehealth.

Dmand AI links 118 papers to Dr. Chauhan, published from 2008 to 2025. 2024 was the busiest year, with 10. The most frequent topics are Neuroendocrine Tumors, Pancreatic Neoplasms and Diagnosis, Differential. Dr. Chauhan has published most often in Clin Pediatr (Phila). Dr. Chauhan's most frequent co-authors are Lowell Brian Anthony, MD, Charles A. Kunos, MD, PhD and Susanne Markesbery Arnold, MD.

Dmand AI links Dr. Chauhan to 10 clinical trials, 5 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Neuroendocrine Tumors, Neuroectodermal Tumors and Gastro-enteropancreatic neuroendocrine tumor. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 115 general payments to Dr. Chauhan from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 62% of the total. Exelixis Inc. paid the most, $28,784. It also lists 5 research payments totaling $16,201 from 2022 to 2025.

Dr. Chauhan graduated from Kasturba Medical College Manipal in 2010.

Dr. Chauhan is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.